Amicus Therapeutics’ Gene Therapy for Rare, Fatal Childhood Disease Shows Promise in Study

, , , , , , ,

Amicus Therapeutics announced positive interim results from the company’s CLN6 Batten disease gene therapy program.

Read more
/by